|
Volumn 18, Issue 5, 2010, Pages 1834-1843
|
Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as l-DOPA prodrugs
|
Author keywords
Dopamine release; DPPH; l DOPA prodrug; Parkinson's disease
|
Indexed keywords
1,1 DIPHENYL 2 PICRYLHYDRAZYL;
IMIDAZOLE DERIVATIVE;
IMIDAZOLINE 4 ONE;
LEVODOPA;
METHYL 2 [4 (3,4 DIHYDROXYBENZYL) 2,2 DIETHYL 5 OXOIMIDAZOLIDIN 1 YL] ACETATE;
METHYL 2 [4 (3,4 DIHYDROXYBENZYL) 2,2 DIMETHYL 5 OXOIMIDAZOLIDIN 1 YL] ACETATE;
PRODRUG;
SCAVENGER;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
ANTIOXIDANT ACTIVITY;
ARTICLE;
BRAIN LEVEL;
CONTROLLED STUDY;
CORPUS STRIATUM;
DOPAMINERGIC ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG RELEASE;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENANTIOMER;
ENZYME STABILITY;
HUMAN;
HYDROLYSIS;
INTESTINE ABSORPTION;
NEUROCHEMISTRY;
NONHUMAN;
SOLUBILITY;
STOMACH;
ADMINISTRATION, ORAL;
ANIMALS;
DOPAMINE;
DRUG DESIGN;
FREE RADICAL SCAVENGERS;
HUMANS;
HYDROLYSIS;
IMIDAZOLES;
KINETICS;
LEVODOPA;
NEUROPROTECTIVE AGENTS;
PARKINSON DISEASE;
PRODRUGS;
RATS;
|
EID: 77249113697
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.01.041 Document Type: Article |
Times cited : (30)
|
References (29)
|